PMID: 9535439Apr 16, 1998Paper

Creation of viable pulmonary artery autografts through tissue engineering

The Journal of Thoracic and Cardiovascular Surgery
Toshiharu ShinokaJ E Mayer

Abstract

"Repair" of many congenital cardiac defects requires the use of conduits to establish right ventricle to pulmonary artery continuity. At present, available homografts or prosthetic conduits lack growth potential and can become obstructed by tissue ingrowth or calcification leading to the need for multiple conduit replacements. Tissue engineering is an approach by which cells are grown in vitro onto biodegradable polymers to construct "tissues" for implantation. A tissue engineering approach has recently been used to construct living cardiac valve leaflets from autologous cells in our laboratory. This study assesses the feasibility of a tissue engineering approach to constructing tissue-engineered "living" pulmonary artery conduits. Ovine artery (group A, n = 4) or vein (group V, n = 3) segments were harvested, separated into individual cells, expanded in tissue culture, and seeded onto synthetic biodegradable (polyglactin/polyglycolic acid) tubular scaffolds (20 mm long x 15 mm diameter). After 7 days of in vitro culture, the autologous cell/polymer vascular constructs were used to replace a 2 cm segment of pulmonary artery in lambs (age 68.4 +/- 15.5 days, weight 18.7 +/- 2.0 kg). One other control animal received an acellular...Continue Reading

References

Jan 1, 1992·Cytotechnology·S P Massia, J A Hubbell
Aug 1, 1969·The Annals of Thoracic Surgery·C H Sparks
Mar 1, 1980·Analytical Biochemistry·C Labarca, K Paigen
Oct 1, 1994·Journal of Cellular Biochemistry·T Ziegler, R M Nerem
Jan 1, 1996·Nature Medicine·S K Williams, B E Jarrell
Dec 1, 1995·The Annals of Thoracic Surgery·T ShinokaJ E Mayer
Jun 5, 1996·Biotechnology and Bioengineering·C K BreuerJ P Vacanti

❮ Previous
Next ❯

Citations

Jun 5, 1999·Journal of Biomedical Materials Research·P X Ma, R Zhang
May 29, 2000·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·K SatoK Tabayashi
Apr 21, 2005·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·O E TeebkenA Haverich
May 20, 2011·Annals of Biomedical Engineering·Lindsey M OttMichael S Detamore
Aug 10, 2006·Journal of Materials Science. Materials in Medicine·Na MeiGuo-Qiang Chen
Jan 24, 2007·Stem Cell Reviews·Christian BreymannS P Hoerstrup
May 28, 2005·The Annals of Thoracic Surgery·Gilbert H L TangRen-Ke Li
May 4, 2005·The Journal of Thoracic and Cardiovascular Surgery·Narutoshi HibinoHiromi Kurosawa
Oct 3, 2009·Cell Stem Cell·Emil M HanssonKenneth R Chien
May 9, 2003·The Annals of Thoracic Surgery·Rainer G LeyhHeike Mertsching
Jan 5, 2000·The Annals of Thoracic Surgery·D Shum-TimJ E Mayer
Aug 16, 2000·Advanced Drug Delivery Reviews·P A TrescoM D Noble
Jun 6, 2000·Advanced Drug Delivery Reviews· Marler Vacanti
Jun 17, 2000·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·M HomannR Lange
Feb 13, 2001·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·A J LevineW J Brawn
Mar 16, 2013·International Journal of Oral Science·Jing GuoGuo-Qiang Guan
Aug 13, 1998·Nature Medicine·B R Unsworth, P I Lelkes
Feb 28, 2001·The New England Journal of Medicine·T Shin'okaY Ikada
Feb 27, 2001·Tissue Engineering·J ZeltingerB Sibanda
May 13, 2003·Tissue Engineering·Boris A NasseriJoseph P Vacanti
May 6, 2008·Tissue Engineering. Part B, Reviews·Saejeong Kim, Horst von Recum
Sep 15, 2004·Tissue Engineering·Yuji NaritaYuichi Ueda
May 24, 2007·Tissue Engineering·Yossi GafniDan Gazit
Sep 12, 2008·Tissue Engineering. Part a·Seung-Woo ChoByung-Soo Kim
May 11, 2012·Tissue Engineering. Part B, Reviews·Vivek K Bajpai, Stelios T Andreadis
Mar 18, 2011·Tissue Engineering. Part C, Methods·Brooks UdelsmanChristopher K Breuer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.